Thanks to companies big and small, research and knowledge of the organisms that live on human skin is advancing, as are personal care technologies that involve the skin microbiome.
“The skin microbiome offers a promising platform for the development and commercialization of natural skin care products more and more people are looking for,” says Heiko Schipper, President of Bayer Consumer Health and a member of the board of management at Bayer AG, in the company’s media release about the new partnership with Azitra.
“As Bayer is committed to the development of science-based consumer health products through our own research as well as external partnerships,” he continues, “we’re delighted to collaborate with Azitra.”
Making skin better with bacteria
Bayer works in the medicated skin care and therapeutic products space; and therefore, the company can develop and use technologies that consumer skin care brands cannot. All the same, partnerships like this one between Bayer and Azitra go a long way to not only to developing new treatment products but also to shape consumer expectation and industry knowledge.
Azitra, owns a library of proprietary strains of staphylococcus epidermidis bacteria and, according to the company site, “is developing products that address both disease and dysbiosis.”
As Schipper notes in the recent media release, “The company has already demonstrated tolerability of a selected Staphylococcus epidermidis strain in healthy volunteers and is now planning to start the clinical demonstration of efficacy.”
"Skin care" - Google News
January 14, 2020 at 11:55PM
https://ift.tt/2TqjRvt
Bayer to develop skin care from bacteria strains - CosmeticsDesign.com USA
"Skin care" - Google News
https://ift.tt/366CDLF
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
No comments:
Post a Comment